Sunday, 26 May 2019

Pharma News

  • Actavis to acquire four products from Akorn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Apr, 2014

    Singapore: Actavis, a leading global specialty pharmaceutical company, has entered into agreements with Akorn and Hi-Tech Pharmacal to purchase four currently marketed products and one prod...Read more

  • Global collaborations is the way forward for drug discovery

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more

  • Abbott to shell out upto $495 mn to acquire Russian firm

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Global pharmaceutical company Abbott plans to acquire Russian pharmaceutical manufacturer, Veropharm in approx. $495 million, to maintain a strong portfolio of oncology drugs in ...Read more

  • India caps FDI in pharma at 49%

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2012

    Bangalore: An inter-ministerial group (IMG) on foreign direct investment (FDI) in pharmaceuticals, headed by Mr Shanktikanta Das, additional secretary, Department of Economic Affairs (DEA),...Read more

  • NIH gives $2.2 mn to VaxInnate for dengue vaccine

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2013

    Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provided funds worth $2.2 million to US based-novel vaccine firm VaxInnate...Read more

  • Japan's UMN joins Protein Sciences-headed Zika Vaccine Consortium

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2016

    Singapore: Protein Sciences Corporation, US-based manufacturer of Flublok influenza vaccine, and UMN Pharma Inc, based out of Japan, have announced that UMN has been signed on as the latest...Read more

  • BMS Foundation awards $1.6 mn to fight diabetes in India

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2012

    Singapore: Bristol-Myers Squibb (BMS) Foundation will provide $1.6 million in grants to four healthcare institutions in India to help improve diabetes education, prevention and care, increa...Read more

  • GSK sales reps were trained to offer sexual bribes

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

    Singapore: Yet another list of shocking insights into the investigation of British drug maker GlaxoSmithKline's bribery scandal has been revealed by the Chinese police. The police have clai...Read more

  • Amgen acquires Turkey-based MN Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2012

    Singapore: Amgen announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat (MN) Pharmaceuticals, a privately held Turkish company. The all-cash tra...Read more

  • Pfizer, Mylan enter generics deal in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 23 Aug, 2012

    Singapore: Pfizer and Mylan have signed a definitive agreement to establish an exclusive long-term strategic collaboration in order to develop, manufacture, distribute and market generic dr...Read more

  • GSK's drug gets 3 months extension form US PDUFA

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: GlaxoSmithKline (GSK) highlighted that the US Prescription Drug User Fee Act (PDUFA) goal date for albiglutide, an investigational once-weekly treatment for adult patients with t...Read more

  • Oramed gets grant from the chief scientist of Israel

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2013

    Singapore: Oramed Pharmaceuticals and its wholly owned Israeli subsidiary, Oramed, has been awarded a government grant from the office of the chief scientist (OCS) at the Ministry of Indust...Read more

  • WuXi PharmaTech facility gets accreditation

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

    Singapore: Pharmaceutical, biotechnology and medical device research and development outsourcing company WuXi PharmaTech's Suzhou toxicology facility, with operations in China and the US, h...Read more

  • ShangPharma retains J P Morgan as financial advisor

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2012

    Singapore: The independent committee of the ShangPharma's board of directors retained J P Morgan Securities as its financial advisor. ShangPharma, which is a leading China-based pharmaceut...Read more

  • China drug market to reach $315 bn by 2020

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: Research and consulting firm GlobalData has pointed out that although various probes into drug pricing and sales practices have plagued China recently, the value of the country's...Read more

  • European Commission nod for Novartis' Exjade

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

    Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or inade...Read more

  • India to examine drug approval procedures

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Bangalore: India has set up a committee to examine the validity of scientific and statutory basis adopted for approval of new drugs without clinical trials. The government announced the dec...Read more

  • CSL hemophilia therapy gets orphan drug status

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP), which can be used for the treatment of Hemophilia B, has been gran...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls